-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

722.O1.6 722. Clinical Allogeneic Transplantation: Acute and Chronic GvHD, Immune Reconstitution: Phase I and II Trials

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
apheresis, Adult, antibodies, Biological, HSCs, ALL, AML, Leukemia, Diseases, bioengineering, bone marrow, Non-Biological, Therapies, biopsy, cell regulation, GVHD, Pediatric, Adverse Events, MDS, enzyme inhibitors, Biological Processes, MPN, gene therapy, cell expansion, Technology and Procedures, immune cells, Immune Disorders, Young Adult, cytogenetics, immunotherapy, Cell Lineage, Lymphoid Malignancies, Study Population, gene editing, Clinically relevant, Myeloid Malignancies, NK cells, genomics, Quality Improvement , hematopoiesis, immune mechanism, flow cytometry, transplantation, TKI, inflammation, stem cells, molecular testing, vaccines, signal transduction
Sunday, December 6, 2020: 9:30 AM-11:00 AM
Moderators:
Ken-Ichi Matsuoka, MD, PhD, Okayama University Hospital and Rohtesh S. Mehta, MD, MPH, MS, The University of Texas MD Anderson Cancer Center
Disclosures:
No relevant conflicts of interest to declare.
9:30 AM

Corey Cutler, MD, MPH, FRCPC 1, Stephanie J. Lee, MD, MPH2, Sally Arai, MD, MS3, Marcello Rotta, MD4, Behyar Zoghi, MD5*, Aravind Ramakrishnan, MD6, David Eiznhamer, PhD7*, Olivier Schueller, PhD8*, Zhongming Yang, PhD9*, Laurie S. Green, MEd10*, Sanjay K. Aggarwal, MD8*, Bruce R. Blazar, MD11, Steven Z. Pavletic, MD, MS12 and Madan Jagasia, MBBS, MS, MMHC13

1Division of Stem Cell Transplantation and Cellular Therapy, Dana-Farber Cancer Inst., Boston, MA
2Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
3Division of Blood and Marrow Transplantation, Stanford University, Stanford, CA
4Sarah Cannon Blood Cancer Network, Colorado Blood Cancer Institute, Denver, CO
5Texas Transplant Specialists, San Antonio, TX
6Sarah Cannon Blood Cancer Center at St. David's South Austin Medical Center, Austin, TX
7Kadmon Corporation, Bloomingdale, IL
8Kadmon Corporation, LLC, New York, NY
9Kadmon Corporation, Cambridge, MA
10Kadmon Corporation, LLC, New York City, NY
11Division of Pediatric Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN
12Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
13Vanderbilt University Medical Center, Nashville, TN

9:45 AM

Everett H Meyer, MD, PhD1*, Rasmus Hoeg, MD2*, Anna Moroz, MD, PhD3*, Bryan Xei, BS4*, Hsin-Hsu Wu, MD5*, Rahul Pawar5*, Kartoosh Heydari, MD5*, David B. Miklos, MD, PhD1, Parveen Shiraz, MD1, Lori Muffly, MD, MS6, Sally Arai, MD, MS1, Laura J. Johnston, MD1, Robert Lowsky, MD, FRCP1, Andrew R. Rezvani, MD1, Judith A Shizuru, MD, PhD1, Wen-Kai Weng, MD, PhD7, Nathaniel Fernhoff, PhD8*, Gerhard Bauer9*, Arpita Gandhi, MD, MS10*, Amy Putnam8*, J. Scott Scott McClellan, MD, PhD11, Bronwen E. Shaw, PhD, MRCP, FRCPath12, Joseph P. McGuirk, DO13, Mehrdad Abedi, MD14 and Robert S. Negrin, MD1

1Division of Blood and Marrow Transplantation, Stanford University, Stanford, CA
2UC Davis, Sacramento, CA
3Blood and Marrow Transplantation, Stanford University, Sanford, CA
4Stanford University, Division of Blood and Marrow Transplantation, Stanford
5Stanford University, Stanford, CA
6Assistant Professor of Medicine, Stanford University School of Medicine, Stanford, CA
7Stanford Univ. School of Med., Stanford, CA
8Orca Bio, Menlo Park, CA
9Institute For Regenerative Cures (IRC), University of California Davis, Sacramento, CA
10Oregon Health Sciences University, Portland, OR
11Orca Bio, Belmont, CA
12CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
13Department of Blood and Bone Marrow Transplant, The University of Kansas Medical Center, Kansas City, KS
14University of California Davis, Sacramento, CA

10:00 AM

Joseph Pidala, MD1, Kelly Walton2*, Hany Elmariah, MD, MS3, Jongphil Kim, PhD4*, Asmita Mishra, MD1*, Nelli Bejanyan, MD5, Taiga Nishihori, MD6, Farhad Khimani, MBBS7, Lia Perez, MD1*, Rawan Faramand, MD8, Marco L. Davila, MD, PhD9, Michael Nieder, MD1*, Nicholas Lawrence, PhD10*, Harshani Lawrence, PhD11*, Claudio Anasetti, MD1, Said Sebti, PhD12* and Brian C. Betts, MD13

1Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
2Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN
3Sidney Kimmel Comprehensive Cancer Center, Moffitt Cancer Center, Tampa, FL
4Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL
5Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
6Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
7Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
8Dept. of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
9H. Lee Moffitt Cancer Center, Tampa, FL
10H Lee Moffitt Cancer Center and Research Institute, Tampa
11Chemical Biology Core, H Lee Moffitt Cancer Center and Research Institute, Tampa
12Virginia Commonwealth University, Richmond, VA
13Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN

10:15 AM

Hannah Choe, MD1, Nirav N. Shah, MD2, Patrice Chevallier, MD, PhD3, Marie Thérèse Rubio, MD, PhD4*, Mark A. Schroeder, MD5, Nancy M. Hardy, MD6, Patrick J. Stiff, MD7, Carlos Solano, MD, PhD8*, Ibrahim Yakoub-Agha9, Jonathan A. Gutman, MD10, Scott D. Rowley, MD11, Maria Caterina Mico', MD12*, Elisabetta Terruzzi, MD13*, Rafael F. Duarte, MD, PhD, FRCP14, Rodica Morariu-Zamfir, MD15*, Michael Arbushites15*, Kai Ding, PhD15* and Miguel-Angel Perales, MD16

1The Ohio State University, Columbus, OH
2Froedtert Hospital and the Medical College of Wisconsin, Milwaukee, WI
3CHU de Nantes, Nantes, France
4CHRU Nancy, Hôpital Brabois, Vandœuvre-les Nancy, France
5Washington University School of Medicine, Saint Louis, MO
6University of Maryland, Greenebaum Cancer Center, Baltimore, MD
7Loyola University Medical Center, Maywood, IL
8Hospital Clinico Universitario, University of Valencia, Valencia, Spain
9CHU de Lille, Univ Lille, INSERM U1286, Infinite, 59000 Lille, France
10Anschutz Cancer Pavilion, University of Colorado, Aurora, CO
11John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
12Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
13Azienda Ospedaliera San Gerardo di Monza, Monza, Italy
14Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain
15Incyte Corporation, Wilmington, DE
16Memorial Sloan Kettering Cancer Center, New York, NY

10:30 AM

Noa G. Holtzman, MD1, Annie Im, MD2, Alen Ostojic, MD1, Lauren M. Curtis, MD3, Laura Parsons-Wandell, RN1*, Jeannette Nashed, BSN MSN CRNP1*, Cody Peer, PhD4*, William D. Figg Sr., PharmD5*, M. Teresa Magone, MD6*, Edward W Cowen, MD7*, Jacqueline W Mays, DDS, PhD8*, Frances T. Hakim, PhD9*, Jeremy J. Rose, MS9*, Marie C Pouzelles, PhD10*, Naomi Taylor, MD, PhD10* and Steven Z. Pavletic, MD, MS1

1Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
2Univ. of Pittsburgh Cancer Institute, Pittsburgh, PA
3Sibley Memorial Hospital, Sidney Kimmel Cancer Center, Johns Hopkins Medicine, Washington, DC
4Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
5Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
6National Eye Institute, National Institutes of Health, Bethesda, MD
7Dermatology Branch, National Institute for Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD
8Oral Immunobiology Unit, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD
9Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
10Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD

10:45 AM

Mukta Arora, MD1, Madan Jagasia, MBBS, MS, MMHC2, Antonio Di Stasi, MD3, Michael L Meyers, MD, PhD4*, Christine Quaranto4*, Aaron Schmitt4*, Serap Sankoh4*, Mohammad Issam Abu Zaid, MBBS5, Geoff R Hill, MD6, Daniel J. Weisdorf, MD7, Bruce R. Blazar, MD8, Peter Ordentlich, PhD4* and Stephanie J. Lee, MD, MPH9

1Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
2Vanderbilt University Medical Center, Nashville, TN
3University of Alabama at Birmingham, Birmingham, AL
4Syndax Pharmaceuticals, Inc, Waltham
5Indiana University Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN
6Fred Hutchinson Cancer Research Center, Seattle, WA
7Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN
8Division of Pediatric Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN
9Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA

*signifies non-member of ASH